Gland Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CYSTEAMINE HYDROCHLORIDE, with a corresponding US DMF Number 37415.
Remarkably, this DMF maintains an Active status since its submission on August 30, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 23, 2023, and payment made on February 09, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II